Melexis Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Melexis hat ein Gesamteigenkapital von €604.9M und eine Gesamtverschuldung von €187.6M, wodurch sich der Verschuldungsgrad auf 31% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €897.1M bzw. €292.1M. Melexis Das EBIT des Unternehmens beträgt €253.8M, so dass der Zinsdeckungsgrad 41.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €34.7M.
Wichtige Informationen
31.0%
Verhältnis von Schulden zu Eigenkapital
€187.61m
Verschuldung
| Zinsdeckungsgrad | 41.8x |
| Bargeld | €34.69m |
| Eigenkapital | €604.95m |
| Gesamtverbindlichkeiten | €292.11m |
| Gesamtvermögen | €897.06m |
Jüngste Berichte zur Finanzlage
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31
Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Recent updates
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 11Should You Think About Buying Melexis NV (EBR:MELE) Now?
Oct 01Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Aug 31There's Reason For Concern Over Melexis NV's (EBR:MELE) Price
Aug 19Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Aug 02A Look At The Fair Value Of Melexis NV (EBR:MELE)
Jul 04Is There Now An Opportunity In Melexis NV (EBR:MELE)?
Jun 20Melexis (EBR:MELE) Knows How To Allocate Capital
Jun 07Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment
May 08Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Should You Think About Buying Melexis NV (EBR:MELE) Now?
Nov 18Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: MELEDie kurzfristigen Aktiva des Unternehmens (€474.5M) übersteigen seine kurzfristigen Passiva (€92.7M).
Langfristige Verbindlichkeiten: MELEDie kurzfristigen Vermögenswerte des Unternehmens (€474.5M) übersteigen seine langfristigen Verbindlichkeiten (€199.4M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: MELEDie Nettoverschuldung im Verhältnis zum Eigenkapital (25.3%) wird als zufriedenstellend angesehen.
Schulden abbauen: MELEDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 18.4% auf 31% gestiegen.
Schuldendeckung: MELEDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (90.2%).
Zinsdeckung: MELEDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (41.8x Coverage) gut gedeckt.